245 related articles for article (PubMed ID: 18396857)
1. Synthesis and biological activity of fluorinated combretastatin analogues.
Alloatti D; Giannini G; Cabri W; Lustrati I; Marzi M; Ciacci A; Gallo G; Tinti MO; Marcellini M; Riccioni T; Guglielmi MB; Carminati P; Pisano C
J Med Chem; 2008 May; 51(9):2708-21. PubMed ID: 18396857
[TBL] [Abstract][Full Text] [Related]
2. Novel combretastatin analogues endowed with antitumor activity.
Simoni D; Romagnoli R; Baruchello R; Rondanin R; Rizzi M; Pavani MG; Alloatti D; Giannini G; Marcellini M; Riccioni T; Castorina M; Guglielmi MB; Bucci F; Carminati P; Pisano C
J Med Chem; 2006 Jun; 49(11):3143-52. PubMed ID: 16722633
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
Pirali T; Busacca S; Beltrami L; Imovilli D; Pagliai F; Miglio G; Massarotti A; Verotta L; Tron GC; Sorba G; Genazzani AA
J Med Chem; 2006 Aug; 49(17):5372-6. PubMed ID: 16913727
[TBL] [Abstract][Full Text] [Related]
4. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
Siles R; Ackley JF; Hadimani MB; Hall JJ; Mugabe BE; Guddneppanavar R; Monk KA; Chapuis JC; Pettit GR; Chaplin DJ; Edvardsen K; Trawick ML; Garner CM; Pinney KG
J Nat Prod; 2008 Mar; 71(3):313-20. PubMed ID: 18303849
[TBL] [Abstract][Full Text] [Related]
5. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A.
Mu F; Hamel E; Lee DJ; Pryor DE; Cushman M
J Med Chem; 2003 Apr; 46(9):1670-82. PubMed ID: 12699385
[TBL] [Abstract][Full Text] [Related]
9. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimicrotubule activity of combretatropone derivatives.
Janik ME; Bane SL
Bioorg Med Chem; 2002 Jun; 10(6):1895-903. PubMed ID: 11937347
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
[TBL] [Abstract][Full Text] [Related]
12. A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
Naret T; Bignon J; Bernadat G; Benchekroun M; Levaique H; Lenoir C; Dubois J; Pruvost A; Saller F; Borgel D; Manoury B; Leblais V; Darrigrand R; Apcher S; Brion JD; Schmitt E; Leroux FR; Alami M; Hamze A
Eur J Med Chem; 2018 Jan; 143():473-490. PubMed ID: 29202409
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
Monk KA; Siles R; Hadimani MB; Mugabe BE; Ackley JF; Studerus SW; Edvardsen K; Trawick ML; Garner CM; Rhodes MR; Pettit GR; Pinney KG
Bioorg Med Chem; 2006 May; 14(9):3231-44. PubMed ID: 16442292
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
Pettit GR; Melody N; Thornhill A; Knight JC; Groy TL; Herald CL
J Nat Prod; 2009 Sep; 72(9):1637-42. PubMed ID: 19719153
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of double bond substituted combretastatins.
Hadfield JA; Gaukroger K; Hirst N; Weston AP; Lawrence NJ; McGown AT
Eur J Med Chem; 2005 Jun; 40(6):529-41. PubMed ID: 15922837
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of mustard derivatives of combretastatins.
Coggiola B; Pagliai F; Allegrone G; Genazzani AA; Tron GC
Bioorg Med Chem Lett; 2005 Aug; 15(15):3551-4. PubMed ID: 15963722
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.
Pettit GR; Toki BE; Herald DL; Boyd MR; Hamel E; Pettit RK; Chapuis JC
J Med Chem; 1999 Apr; 42(8):1459-65. PubMed ID: 10212132
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J
Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors.
Romagnoli R; Oliva P; Salvador MK; Camacho ME; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Grillo E; Bortolozzi R; Rruga F; Mariotto E; Viola G
Eur J Med Chem; 2019 Nov; 181():111577. PubMed ID: 31400707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
